Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction

被引：38
作者：
Castano, Adam [1 ]
Bokhari, Sabahat [1 ]
Maurer, Mathew S. [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Div Cardiol, Ctr Adv Cardiac Care, New York, NY 10032 USA
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷 / 38期
关键词：
COMORBIDITIES; SCINTIGRAPHY;
D O I：
10.1093/eurheartj/ehv328
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2595 / 2597
页数：3
相关论文
共 16 条
[1]  
[Anonymous], 2014, PHASE 2 STUDY EVALUA
[2]  
[Anonymous], 2014, SAFETY EFFICACY TAFA
[3]   Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin Transthyretin Cardiac Amyloid Study (TRACS) [J].
Bhuiyan, Taslima ;
Helmke, Stephen ;
Patel, Ayan R. ;
Ruberg, Frederick L. ;
Packman, Jeff ;
Cheung, Kin ;
Grogan, Donna ;
Maurer, Mathew S. .
CIRCULATION-HEART FAILURE, 2011, 4 (02) :121-128
[4]   99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses [J].
Bokhari, Sabahat ;
Castano, Adam ;
Pozniakoff, Ted ;
Deslisle, Susan ;
Latif, Farhana ;
Maurer, Mathew S. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (02) :195-201
[5]   Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis [J].
Coelho, Teresa ;
Adams, David ;
Silva, Ana ;
Lozeron, Pierre ;
Hawkins, Philip N. ;
Mant, Timothy ;
Perez, Javier ;
Chiesa, Joseph ;
Warrington, Steve ;
Tranter, Elizabeth ;
Munisamy, Malathy ;
Falzone, Rick ;
Harrop, Jamie ;
Cehelsky, Jeffrey ;
Bettencourt, Brian R. ;
Geissler, Mary ;
Butler, James S. ;
Sehgal, Alfica ;
Meyers, Rachel E. ;
Chen, Qingmin ;
Borland, Todd ;
Hutabarat, Renta M. ;
Clausen, Valerie A. ;
Alvarez, Rene ;
Fitzgerald, Kevin ;
Gamba-Vitalo, Christina ;
Nochur, Saraswathy V. ;
Vaishnaw, Akshay K. ;
Sah, Dinah W. Y. ;
Gollob, Jared A. ;
Suhr, Ole B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :819-829
[6]  
Givens Raymond C, 2013, Aging health, V9, P229
[7]   Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis [J].
Glaudemans, Andor W. J. M. ;
van Rheenen, Ronald W. J. ;
van den Berg, Maarten P. ;
Noordzij, Walter ;
Koole, Michel ;
Blokzijl, Hans ;
Dierckx, Rudi A. J. O. ;
Slart, Riemer H. J. A. ;
Hazenberg, Bouke P. C. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2014, 21 (01) :35-44
[8]   Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction [J].
Gonzalez-Lopez, Esther ;
Gallego-Delgado, Maria ;
Guzzo-Merello, Gonzalo ;
de Haro-del Moral, F. Javier ;
Cobo-Marcos, Marta ;
Robles, Carolina ;
Bornstein, Belen ;
Salas, Clara ;
Lara-Pezzi, Enrique ;
Alonso-Pulpon, Luis ;
Garcia-Pavia, Pablo .
EUROPEAN HEART JOURNAL, 2015, 36 (38) :2585-2594
[9]   Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes [J].
Maurer, Mathew S. ;
Grogan, Donna R. ;
Judge, Daniel P. ;
Mundayat, Rajiv ;
Packman, Jeff ;
Lombardo, Ilise ;
Quyyumi, Arshed A. ;
Aarts, Janske ;
Falk, Rodney H. .
CIRCULATION-HEART FAILURE, 2015, 8 (03) :519-526
[10]   HFpEF Is Splitting Into Distinct Phenotypes by Comorbidities the Pathway Forward? [J].
Maurer, Mathew S. ;
Mancini, Donna .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (06) :550-552
12